Our results explained that decreased amounts of UHRF1 induced aggravation of RA pathogenesis and/or inhibited beneficial effects of medications, but the mechanisms that contribute to low UHRF1 levels in some patients with RA are unclear. The gene discussed is UHRF1; the disease is rheumatoid arthritis.